The CAR-Immunotherapy results file contains 12 categories of information for 81 full papers and 24 case reports from 76 trials that were published through 31 Dec. 2018. Purchasers will receive FREE UPDATES twice a year for the next two years.

For each publication, the following topics are covered:

  1. Trial ID
  2. Publication ID and link
  3. First/ last author and year of report
  4. Conditions
  5. CAR target
  6. Trial endpoints
  7. Number of patients (enrolled, infused, evaluable)
  8. Safety/ adverse events data
  9. Efficacy data
  10. CAR cells persistence in vivo
  11. Durability of response
  12. Were endpoints met?

Release 5 covers publications up to 31 Dec. 2018.

  • Total number of full papers increases by 12 from 69 to 81 publications.
  • 9 trials added
  • 9 publications added
  • 3 publications IDs (PMID) added to existent data (new papers analyzed different aspects of the same trial)
  • 2 clinical cases added

Release 4 covers publications up to 31 July 2018, including 9 full papers published in the first half of 2018.

  • 2 trial results were updated for liquid malignancies with data from the most recent publications (2018)
  • 4 more trials and 5 new full papers (one trial was not registered) were added to liquid malignancies
  • 2 more trials and 2 new full papers were added to solid malignancies
  • 4 more clinical case reports added (second tab)
  • changes from the previous update are highlighted in green CAR-Immunotherapy trials verus publications

Public samples: